Related Experiment Videos
Coronary artery bypass grafting without cardiopulmonary bypass
Insights
Off-pump coronary artery bypass surgery offers a safe and cost-effective treatment for ischemic heart disease. This technique resulted in no mortality or major complications in 162 patients, including high-risk individuals.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Techniques
- Ischemic Heart Disease Treatment
Background:
- Ischemic heart disease necessitates advanced surgical interventions.
- Conventional coronary bypass surgery carries inherent risks.
- Minimally invasive surgical options are increasingly sought.
Purpose of the Study:
- To evaluate the safety and efficacy of off-pump coronary artery bypass (OPCAB) surgery.
- To assess the outcomes of OPCAB in a cohort of patients with ischemic heart disease.
- To determine the cost-effectiveness of OPCAB compared to other treatment modalities.
Main Methods:
- A retrospective analysis of 162 patients who underwent OPCAB surgery between June 1992 and September 1997.
- Data collection included perioperative outcomes, morbidity, and mortality.
- Cost-effectiveness analysis was performed against conventional bypass surgery.
Main Results:
- No mortality was observed in the study cohort.
- Zero incidence of respiratory or neurological morbidity reported.
- 24% of patients were considered high-risk for conventional coronary bypass surgery.
- OPCAB demonstrated significant cost-effectiveness compared to alternative treatments.
Conclusions:
- Off-pump coronary artery bypass surgery is a safe and effective treatment for selected ischemic heart disease patients.
- The procedure is associated with excellent outcomes, even in high-risk populations.
- Continuous utilization of OPCAB is justified, and cardiac surgeons should gain experience with this technique.
Abstract:
Coronary artery bypass surgery on a beating heart is now an accepted modality to treat selected patients of ischaemic heart disease. From June '92 through Sep '97, 162 patients underwent this procedure. There was no mortality and none of the patients had any respiratory or neurological morbidity, though 24% of the patients form a high risk group for conventional coronary bypass surgery. It is definitely cost effective in comparison to any other modalities for treatment of ischaemic heart disease. We conclude that continous use of this technique is justified and all cardiac surgeons should have exposure to this procedure.